Abstract
The condensation of hydrazine, N-methylhydrazine, and N-phenylhydrazine with ethyl 4-chloro-2-oxo-1,2-dihydroquinoline-3-carboxylate derivatives has been investigated. As a result, 12 new antioxidant pyrazolo[4,3-c]quinolin-3,4-diones were obtained with good to high yields. When two cross-products could be possible, only one isomer bearing the methyl or the phenyl group at the N1 position is isolated and unequivocally characterized using 1D and 2D NMR techniques, FT-IR, and combustion analyses. DFT analysis of the reaction mechanism was carried out in the Pearson’s hard soft acid base framework, confirming the assigned structure to the observed pyrazolo[4,3-c]quinolin-3,4-diones. These calculations indicate a favored kinetic control for the synthesized pyrazolo[4,3-c]quinolin-3,4-diones compared to its possible regioisomer.
Graphical abstract
Similar content being viewed by others
References
Mekheimer RA, Ahmed EA, Sadek KU (2012) Tetrahedron 68:1637
Cin GT, Demirel S, Cakici A (2011) J Organomet Chem 696:613
Savini L, Chiasserini L, Pellerano C, Biggio G, Maciocco E, Serra M, Cinone N, Carrieri A, Altomare C, Carotti A (2001) Bioorg Med Chem 9:431
Carotti A, Altomare C, Savini L, Chiasserini L, Pellerano C, Mascia MP, Maciocco E, Busonero F, Mameli M, Biggio G, Sanna E (2003) Bioorg Med Chem 11:5259
Skotnicki JS, Gilman SC, Steinbaugh BA, Musser JH (1988) Pyrazolo[4,3-c]quinolines as anti inflammatories. US Patent 4,748,246, May 31, 1988; Chem Abstr 109:110425
Baruah B, Dasu K, Vaitilingam B, Vanguri A, Rao Casturi S, Rao Yeleswarapu K (2004) Bioorg Med Chem Lett 14:445
Crespo MI, Gràcia J, Puig C, Vega A, Bou J, Beleta J, Doménech T, Ryder H, Segarra V, Palacios JM (2000) Bioorg Med Chem Lett 10:2661
Wentland MP (1994) Preparation of 5-cyclopropyl-8-fluoro-7-(4-pyridyl)-3H-pyrazolo[4,3-c]quinolin-3-one topoisomerase-inhibiting anticancer agents. US Patent 5,334,595, Aug 02, 1994; Chem Abstr 121:230766
Suzuki F, Nakasato Y, Ohmori K, Tamura T, Hosoe H, Kubo K, Yoshitake I (1995) Preparation of pyrazolo quinolones as antiinflammatories and liver protective agents. Eur Patent 0476544, Mar 25, 1995; Chem Abstr 116:255609
Yokoyama N, Ritter B, Neubert AD (1982) J Med Chem 25:337
Ghotekar BK, Ghagare MG, Toche RB, Jachak MN (2010) Monatsh Chem 141:169
Ismaïli L, Refouvelet B, Robert JF (1999) J Heterocycl Chem 36:719
Truong AP, Aubele DL, Probst GD, Neitzel ML, Semko CM, Bowers S, Dressen D, Hom RK, Konradi AW, Sham HL, Garofalo AW, Keim PS, Wu J, Dappen MS, Wong K, Goldbach E, Quinn KP, Sauer J-M, Brigham EF, Wallace W, Nguyen L, Hemphill SS, Bova MP, Bard F, Yednock TA, Basi G (2009) Bioorg Med Chem Lett 19:4920
Beshore DC, DiPardo RM, Kuduk SD (2010) Tetrahedron Lett 51:970
Kalita PK, Baruah B, Bhuyan PJ (2006) Tetrahedron Lett 47:7779
Shawali AS (1993) Chem Rev 93:2731
Daou B, Soufiaoui M (1989) Tetrahedron 45:3351
Gál M, Fehér Ö, Tihanyi E, Horváth G, Jerkovich G, Argay G, Kálmán A (1980) Tetrahedron Lett 21:1567
Gál M, Fehér Ö, Tihanyi E, Horváth G, Jerkovich G (1982) Tetrahedron 38:2933
López Rivilli MJ, Moyano EL, Yranzo GI (2010) Tetrahedron Lett 51:478
Tomassoli I, Ismaili L, Pudlo M, de Los Ríos C, Soriano E, Colmena I, Gandía L, Rivas L, Samadi A, Marco-Contelles J, Refouvelet B (2011) Eur J Med Chem 46:1
Bjork A, Jonsson S, Fex T, Hedlund G (2000) Preparation of quinoline-3-carboxamides for diseases resulting from autoimmunity and pathol inflammation. US patent 6,077,851, Apr 22, 2000; Chem Abstr 131:322547
Hur W, Sun Z, Jiang T, Mason DE, Peters EC, Zhang DD, Luesch H, Schultz PG, Gray NS (2010) Chem Biol 17:537
Jansson K, Fristedt T, Olsson A, Svensson B, Jönsson S (2006) J Org Chem 71:1658
Tedesco R, Shaw AN, Bambal R, Chai D, Concha NO, Darcy MG, Dhanak D, Fitch DM, Gates A, Gerhardt WG, Halegoua DL, Han C, Hofmann GA, Johnston VK, Kaura AC, Liu N, Keenan RM, Lin-Goerke J, Sarisky RT, Wiggall KJ, Zimmerman MN, Duffy KJ (2006) J Med Chem 49:971
Beutner GL, Kuethe JT, Yasuda N (2007) J Org Chem 72:7058
Chai D, Colon M, Duffy J, Fitch DM, Tedesco R, Zimmerman, MN (2007) Preparation of N-[(4-hydroxy-2-oxo-1,2-dihydro-3-quinolinyl)carbonyl]glycine derivatives as prolyl hydroxylase inhibitors. PCT Int Appl WO 2007038571 A2, Apr 05, 2007; Chem Abstr 146:380309
Tomohiro O, Yuya O, Toshio T, Zenyu S, Sachio S, Yoshihiko S, Hiroko Y, Harumi H, Yukiko Y, Shigeru K, Maki M, Hideaki T, Atsuo B, Satoshi S (2012) Bioorg Med Chem 20:5496
Ponti A (2000) J Phys Chem A 104:8843
Parr RG, Szentpály L, Liu S (1999) J Am Chem Soc 121:1922
Parr RG, Yang RGPW (1989) Density-functional theory of atoms and molecules. Oxford University Press, Oxford
Fleming I (2010) Molecular orbitals and the structures of organic molecules. Wiley, London, p 69
Amarowicz R, Pegg RB, Rahimi-Moghaddam P, Barl B, Weil JA (2004) Food Chem 84:551
Siddhuraju P, Becker K (2007) Food Chem 101:10
Chung S-K, Osawa T, Kawakishi S (1997) Biosci Biotechnol Biochem 61:118
Khirade PW, Chaudhari A, Shinde JB, Helambe SN, Mehrotra SC (1999) J Chem Eng Data 44:879
Cossi M, Rega N, Scalmani G, Barone V (2003) J Comput Chem 24:669
Lee C, Yang W, Parr RG (1988) J Mol Struct (Theochem) 163:305
Hatano T, Kagawa H, Yasuhara T, Okuda T (1988) Chem Pharm Bull (Tokyo) 36:2090
Acknowledgments
The authors thank the Regional University Hospital of Besançon for support (France). Financial support from Regional Council of Franche-Comté (Besançon, France) is also acknowledged. Computations have been performed on the supercomputer facilities of the Mésocentre de calcul de Franche-Comté (Besançon, France).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tomassoli, I., Herlem, G., Picaud, F. et al. Synthesis, regioselectivity, and DFT analysis of new antioxidant pyrazolo[4,3-c]quinoline-3,4-diones. Monatsh Chem 147, 1069–1079 (2016). https://doi.org/10.1007/s00706-016-1660-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00706-016-1660-7